LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214

被引:0
|
作者
Ying Chen [1 ,2 ]
Hui Du [3 ]
Lewen Bao [1 ,2 ]
Wenxin Liu [1 ,2 ]
机构
[1] Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,Tianjin
[2] Tianjin's Clinical Research Center for Cancer
[3] Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical
关键词
D O I
暂无
中图分类号
R737.31 [卵巢肿瘤];
学科分类号
摘要
Objective: Emerging evidence indicates that long non-coding RNAs(lnc RNAs) are critical in carcinogenesis and progression of ovarian cancer. This study aimed to explore the functions and molecular mechanisms of plasmacytoma variant translocation I(PVT1) in ovarian cancer Methods: PVT1 and miR-214 were detected by qRT-PCR assays in ovarian cancer tissues and cells. The cell proliferation,migration, and invasion abilities were detected by cell functional experiments, respectively. Western blot assay was performed to detect epithelial-mesenchymal transition(EMT) markers. MiR-214 expression regulated by PVT1 was studied by RNA immunoprecipitation(RIP) and chromatin immunoprecipitation(Ch IP) assays.Results: The expression of PVT1 was up-regulated in ovarian cancer tissues and cell lines. Elevated PVT1 expression was associated with advanced stage and indicated poor prognosis for ovarian cancer patients. The knockdown of PVT1 impaired SKOV3 cell proliferation, migration, and invasion in vitro. The promotion of ovarian cancer progression by PVT1 involved in regulation of the epithelial-mesenchymal transition process and PVT1 interaction with EZH2 represses miR-214 expression in ovarian cancer cells.Conclusions: PVT1 plays an important role in ovarian cancer tumorigenesis, which might be as a novel diagnostic marker and therapeutic target for ovarian cancer.
引用
收藏
页码:238 / 250
页数:13
相关论文
共 50 条
  • [1] LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
    Ying Chen
    Hui Du
    Lewen Bao
    Wenxin Liu
    Cancer Biology & Medicine, 2018, 15 (03) : 238 - 250
  • [2] LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
    Chen, Ying
    Du, Hui
    Bao, Lewen
    Liu, Wenxin
    CANCER BIOLOGY & MEDICINE, 2018, 15 (03) : 238 - 250
  • [3] Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis
    Xiong, Xiangyu
    Yuan, Jupeng
    Zhang, Nasha
    Zheng, Yan
    Liu, Jibing
    Yang, Ming
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 521 (02) : 478 - 484
  • [4] Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214
    Gou, Xun
    Zhao, Xiyan
    Wang, Zhengrong
    CANCER BIOMARKERS, 2017, 20 (04) : 511 - 519
  • [5] Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140
    Yuqin Ding
    Qianjin Fang
    Yan Li
    Yanni Wang
    Mammalian Genome, 2019, 30 : 217 - 225
  • [6] Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140
    Ding, Yuqin
    Fang, Qianjin
    Li, Yan
    Wang, Yanni
    MAMMALIAN GENOME, 2019, 30 (7-8) : 217 - 225
  • [7] PVT1 Promotes Cancer Progression via MicroRNAs
    Wang, Wenxi
    Zhou, Ruoyu
    Wu, Yuwei
    Liu, Yicong
    Su, Wenjia
    Xiong, Wei
    Zeng, Zhaoyang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression
    Liu, Weiwei
    Yao, Dongmei
    Huang, Bo
    OPEN LIFE SCIENCES, 2021, 16 (01): : 1 - 13
  • [9] lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel
    Naseri, Bahar
    Farsad-Akhtar, Nader
    Mardi, Amirhossein
    Baghbani, Elham
    Bornedeli, Soghra
    Asadi, Milad
    Shanehbandi, Dariush
    GENE, 2025, 932
  • [10] Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b
    Zhang, Shaorong
    Zhang, Guanli
    Liu, Jingying
    APMIS, 2016, 124 (08) : 649 - 658